Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Hormone receptor status is an independent predictor of survival outcome
July 21st, 2005
Hormone receptor status is an independent predictor of survival outcome in women with breast cancer, according to a study from Columbia University. V.R. Grann and colleagues evaluated "hormone receptor status as an independent predictor of survival in a population-based cohort of women with breast carcinoma who were followed for up to 11 years." "Since 1990, the [U.S.] National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program has collected data on hormone receptor status among patients with breast carcinoma," Grann and associates wrote. "In a cohort of 205,736 women with breast carcinoma age {{>=}}20 years at diagnosis...
Source: Women's Health Weekly (2005-07-21)
|
